ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.331,39
-0,25%
S&P 500
5.469,30
0,39%
US Dollar vs BRL
5,4522
0,00%
Bitcoin
62.060,06
0,42%
Brent Oil
84,435
0,30%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Alder BioPharmaceuticals Inc (ALDR)

  7. Alder BioPharmaceuticals Inc (ALDR) Notícias

ALDR

Alder BioPharmaceuticals (ALDR)

Alder BioPharmaceuticals Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ALDR
DataHoraFonteTítuloCódigoCompanhia
13/02/202018:19Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ALDRAlder BioPharmaceuticals Inc
01/11/201912:45Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:ALDRAlder BioPharmaceuticals Inc
31/10/201917:28Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ALDRAlder BioPharmaceuticals Inc
25/10/201907:10Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ALDRAlder BioPharmaceuticals Inc
24/10/201920:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALDRAlder BioPharmaceuticals Inc
22/10/201918:33Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:ALDRAlder BioPharmaceuticals Inc
22/10/201918:13Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ALDRAlder BioPharmaceuticals Inc
22/10/201910:26Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:ALDRAlder BioPharmaceuticals Inc
22/10/201910:15Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ALDRAlder BioPharmaceuticals Inc
22/10/201910:04Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:ALDRAlder BioPharmaceuticals Inc
22/10/201910:04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ALDRAlder BioPharmaceuticals Inc
11/10/201909:00GlobeNewswire Inc.Lundbeck and Alder BioPharmaceuticals announce updated information in the tender offer materials filed with SECNASDAQ:ALDRAlder BioPharmaceuticals Inc
10/10/201913:12Edgar (US Regulatory)Schedule 13gNASDAQ:ALDRAlder BioPharmaceuticals Inc
10/10/201909:01GlobeNewswire Inc.Alder BioPharmaceuticals® Announces First-in-Human Dosing in Phase 1 ALD1910 Study for Preventive Treatment of MigraineNASDAQ:ALDRAlder BioPharmaceuticals Inc
26/09/201915:18Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ALDRAlder BioPharmaceuticals Inc
26/09/201914:26Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ALDRAlder BioPharmaceuticals Inc
23/09/201917:08Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:ALDRAlder BioPharmaceuticals Inc
23/09/201916:25Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:ALDRAlder BioPharmaceuticals Inc
18/09/201917:51Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:ALDRAlder BioPharmaceuticals Inc
17/09/201919:14PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Alder Biopharmaceuticals, Inc.NASDAQ:ALDRAlder BioPharmaceuticals Inc
16/09/201918:15Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:ALDRAlder BioPharmaceuticals Inc
16/09/201912:09PR Newswire (US)Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Alder BioPharmaceuticals has obtained a Fair Price in its sale ...NASDAQ:ALDRAlder BioPharmaceuticals Inc
16/09/201908:46PR Newswire (US)Alder (ALDR) Alert: Johnson Fistel Investigates Proposed Sale of Alder BioPharmaceuticals, Inc.; Are Shareholders Getting a F...NASDAQ:ALDRAlder BioPharmaceuticals Inc
05/09/201917:01GlobeNewswire Inc.Alder BioPharmaceuticals® to Showcase Data from Migraine Prevention Portfolio at 19th Congress of the International Headache...NASDAQ:ALDRAlder BioPharmaceuticals Inc
04/09/201910:00PR Newswire (US)Bolt Biotherapeutics Appoints Veteran Executive Randall Schatzman as CEO to Lead the Next Phase of GrowthNASDAQ:ALDRAlder BioPharmaceuticals Inc
30/08/201917:01GlobeNewswire Inc.Alder BioPharmaceuticals® Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ALDRAlder BioPharmaceuticals Inc
28/08/201917:01GlobeNewswire Inc.Alder BioPharmaceuticals® to Present at Two Upcoming September Investor ConferencesNASDAQ:ALDRAlder BioPharmaceuticals Inc
06/08/201917:07GlobeNewswire Inc.Alder BioPharmaceuticals® Reports Second Quarter 2019 Financial and Operating ResultsNASDAQ:ALDRAlder BioPharmaceuticals Inc
06/08/201917:03Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ALDRAlder BioPharmaceuticals Inc
02/08/201917:01GlobeNewswire Inc.Alder BioPharmaceuticals® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ALDRAlder BioPharmaceuticals Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:ALDR

Seu Histórico Recente

NYSE
FNB-E
FNB
COIN
EQMGBP
LATK
KRC7BTC
Kurecoin Token
BIT
P1YX47
NLBNPIT1YX47 20991231 2....
TSX
UDEF.B
Manulife Smart US Defens...
TG
9GA7
WisdomTree Commodity Sec...
LSE
VNH
Vietnam
LSE
EURO
Frk Eur Igc Etf
NASDAQ
PTOCU
Pine Technology Acquisit...
COIN
HAOUSD
History Dao Token
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados